ChineseInvestors.com Inc. (CIIX) Announces 175% Sa
Post# of 346
(Total Views: 109)
Posted On: 09/17/2019 4:23:13 PM
ChineseInvestors.com Inc. (CIIX) Announces 175% Sales Increase, Launch of Six New Hemp-Infused Skincare Products
- ChineseInvestors.com is a leading financial information website for Chinese-speaking investors
- The company reported a 175 percent year-over-year increase in revenue for FY2019
- CIIX’s CBD Biotech Inc. division recently launched six new skincare products
ChineseInvestors.com Inc. (OTCQB: CIIX) is a foremost financial information website for Chinese-speaking investors in the United States and China. In addition, via its CBD division (CBD Biotech Inc.), the company was focusing on cannabidiol (CBD)-based nutrition and health products. However, the company’s current plan is to return focus to its original mission of providing financial information and services to the larger Chinese community in the United States and elsewhere. Established in 1999, ChineseInvestors.com is based in San Gabriel, California (http://nnw.fm/tJG1l), and it has been operating its premier financial information website for 18 years.
CIIX offers an array of investor education products and services on its main website, www.ChineseInvestors.com. The company provides real-time market commentary, analysis and education-related services in Chinese language character sets, including both traditional and simplified. The company also offers its proprietary ChineseInvestors Method, an innovative integration of a disciplined investing process, web-based tools, personalized instructions and support. Therefore, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
Moreover, CIIX provides consultative services to smaller private businesses that are considering going public. The company also provides advertising and public relations-related support services. Additionally, CIIX raises awareness through investor conferences and road shows.
Recently, CIIX provided an update on its financial results for the fiscal year ended May 31, 2019, as well as an outlook for fiscal year 2020 (http://nnw.fm/3eHno). The company reported a 175 percent year-over-year increase in revenue for FY2019, with $4,189,935 in sales revenue from industrial hemp and CBD liquor products in FY2019. This number is up from $378,984 in FY2018.
Furthermore, CIIX reported $1,336,402 in investor relations revenues in FY2019, up from $968,282 in FY2018. The company’s subscription revenue in FY2019 was $865,457, up from $779,964 in FY2018. The majority (95 percent) of CIIX’s subscriber base (free and paid members) is located in the United States and Canada. The company’s services are generally delivered to U.S. public and private businesses and also U.S. residents and citizens (http://nnw.fm/7hsQS).
“While we have been strategically focusing on industrial hemp and CBD sales, we are pleased with the progress we have seen in our legacy businesses, financial news, education subscriptions, and investor relations, where we are re-focused on organic growth,” CIIX CEO Warren Wang stated in a news release. “We expect to see the full result of these efforts in FY2020.”
Wang also noted that CIIX hopes for a Nasdaq IPO of CBD Biotech late in FY2019 or early next year. CIIX would then concentrate on identifying an acquisition target for further growth (http://nnw.fm/k1C1T).
In addition, CIIX recently announced that CBD Biotech launched six new products in combination with its long-term strategic plans to expand its hemp/CBD skincare offerings. CBD Biotech’s new products include CBD Oligopeptides Repair Eye Cream, CBD Nerve Acylamide Eye Essence, CBD Hemp Eye Mask, CBD Gold Nicotinamide Essence, CBD Handmade Horse Oil Soap and CBD Clear Bright. These products are designed to complement the company’s present skincare lines and increase brand loyalty and awareness.
CIIX is re-focusing on its legacy business of providing first-rate financial information and services to the larger Chinese community. Of note for investors is that the company anticipates doubling its sales over the next 12 months. CIIX continues to execute on its strategy of solidifying its position as the leading financial information website for Chinese-speaking investors in the U.S. and China.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- ChineseInvestors.com is a leading financial information website for Chinese-speaking investors
- The company reported a 175 percent year-over-year increase in revenue for FY2019
- CIIX’s CBD Biotech Inc. division recently launched six new skincare products
ChineseInvestors.com Inc. (OTCQB: CIIX) is a foremost financial information website for Chinese-speaking investors in the United States and China. In addition, via its CBD division (CBD Biotech Inc.), the company was focusing on cannabidiol (CBD)-based nutrition and health products. However, the company’s current plan is to return focus to its original mission of providing financial information and services to the larger Chinese community in the United States and elsewhere. Established in 1999, ChineseInvestors.com is based in San Gabriel, California (http://nnw.fm/tJG1l), and it has been operating its premier financial information website for 18 years.
CIIX offers an array of investor education products and services on its main website, www.ChineseInvestors.com. The company provides real-time market commentary, analysis and education-related services in Chinese language character sets, including both traditional and simplified. The company also offers its proprietary ChineseInvestors Method, an innovative integration of a disciplined investing process, web-based tools, personalized instructions and support. Therefore, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
Moreover, CIIX provides consultative services to smaller private businesses that are considering going public. The company also provides advertising and public relations-related support services. Additionally, CIIX raises awareness through investor conferences and road shows.
Recently, CIIX provided an update on its financial results for the fiscal year ended May 31, 2019, as well as an outlook for fiscal year 2020 (http://nnw.fm/3eHno). The company reported a 175 percent year-over-year increase in revenue for FY2019, with $4,189,935 in sales revenue from industrial hemp and CBD liquor products in FY2019. This number is up from $378,984 in FY2018.
Furthermore, CIIX reported $1,336,402 in investor relations revenues in FY2019, up from $968,282 in FY2018. The company’s subscription revenue in FY2019 was $865,457, up from $779,964 in FY2018. The majority (95 percent) of CIIX’s subscriber base (free and paid members) is located in the United States and Canada. The company’s services are generally delivered to U.S. public and private businesses and also U.S. residents and citizens (http://nnw.fm/7hsQS).
“While we have been strategically focusing on industrial hemp and CBD sales, we are pleased with the progress we have seen in our legacy businesses, financial news, education subscriptions, and investor relations, where we are re-focused on organic growth,” CIIX CEO Warren Wang stated in a news release. “We expect to see the full result of these efforts in FY2020.”
Wang also noted that CIIX hopes for a Nasdaq IPO of CBD Biotech late in FY2019 or early next year. CIIX would then concentrate on identifying an acquisition target for further growth (http://nnw.fm/k1C1T).
In addition, CIIX recently announced that CBD Biotech launched six new products in combination with its long-term strategic plans to expand its hemp/CBD skincare offerings. CBD Biotech’s new products include CBD Oligopeptides Repair Eye Cream, CBD Nerve Acylamide Eye Essence, CBD Hemp Eye Mask, CBD Gold Nicotinamide Essence, CBD Handmade Horse Oil Soap and CBD Clear Bright. These products are designed to complement the company’s present skincare lines and increase brand loyalty and awareness.
CIIX is re-focusing on its legacy business of providing first-rate financial information and services to the larger Chinese community. Of note for investors is that the company anticipates doubling its sales over the next 12 months. CIIX continues to execute on its strategy of solidifying its position as the leading financial information website for Chinese-speaking investors in the U.S. and China.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Chineseinvestors.com Inc. (CIIX) Stock Research Links
Scroll down for more posts ▼